Medwing
Entry
2023
Hold
3yr
Status
Active
Who owns Medwing?
Medwing is currently owned by Quadrille Capital through Quadrille Technologies IV (2021 vintage), since 2023. Across its history, Medwing has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Quadrille CapitalQuadrille Technologies IV · 2021 · VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Atlantic Labs, Northzone Ventures, Cathay Capital and Quadrille Capital since 2017.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2017 · present
Atlantic LabsActive
2017 · present(9yr) · Atlantic Labs I · 2013 · Evergreen
Northzone VenturesActive
2019 · present(7yr) · Northzone VIII · 2019 · VC
Cathay CapitalActive
2020 · present(6yr) · Cathay Innovation Fund II · 2019 · VC
Quadrille CapitalActive
2023 · present(3yr) · Quadrille Technologies IV · 2021 · VC
More from Quadrille Technologies IV
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Track Medwing
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Medwing?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Medwing.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue